Cost-effectiveness of eptifibatide in patients undergoing planned coronary stenting: Results from the ESPRIT trial

被引：0
|
作者：
Cohen, DJ
Cosgrove, RS
Berezin, RH
O'Shea, J
Kitt, MM
Gilchrist, I
Mark, DB
Tcheng, JE
机构：
[1] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[2] Harvard Clin Res Inst, Boston, MA USA
[3] Duke Clin Res Inst, Durham, NC USA
[4] Cor Therapeut, San Francisco, CA USA
[5] Penn State Univ, Coll Med, College Stn, PA USA
来源：
CIRCULATION | 2001年 / 104卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1841
引用
收藏
页码：386 / 387
页数：2
相关论文
共 50 条
  • [41] Cost effectiveness of paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization - Results from the TAXUS-IV trial
    Bakhai, Ameet
    Stone, Gregg W.
    Mahoney, Elizabeth
    Lavelle, Tara A.
    Shi, Chunxue
    Berezin, Ronna H.
    Lahue, Betsy J.
    Clark, Mary Ann
    Lacey, Michael J.
    Russell, Mary E.
    Ellis, Stephen G.
    Hermiller, James B.
    Cox, David A.
    Cohen, David J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (02) : 253 - 261
  • [42] Cost-effectiveness of an invasive strategy in unstable coronary artery disease -: Results from the FRISC II invasive trial
    Janzon, M
    Levin, LÅ
    Swahn, E
    EUROPEAN HEART JOURNAL, 2002, 23 (01) : 31 - 40
  • [43] Long-term cost-effectiveness of invasive strategy in patients with unstable coronary artery disease -: Results from the FRISC II trial
    Janzon, M
    Levin, LÅ
    Swahn, E
    CIRCULATION, 2003, 108 (17) : 467 - 467
  • [44] Cost-effectiveness of abciximab after coronary stenting: A decision-analytic model
    Rodriguez, O
    Cutlip, DE
    Kuntz, RE
    Cohen, DJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (02) : 51A - 51A
  • [45] Cost-effectiveness of surgery for venous ulceration: early results from the ESCHAR trial
    Whitman, B
    Barwell, J
    Davies, C
    Taylor, M
    Heather, BP
    Whyman, MR
    Poskitt, KR
    Earnshaw, JJ
    BRITISH JOURNAL OF SURGERY, 2003, 90 : 116 - 116
  • [46] Cost-effectiveness of eletriptan versus zolmitriptan: Results from a randomized controlled trial
    Mullins, CD
    Healey, PJ
    Mychaskiw, M
    Meng, F
    Weis, KA
    VALUE IN HEALTH, 2005, 8 (03) : 318 - 318
  • [47] COST-EFFECTIVENESS OF CHEMOPREVENTION WITH DUTASTERIDE BASED ON RESULTS FROM THE REDUCE CLINICAL TRIAL
    Earnshaw, S. R.
    McDade, C. L.
    Black, L.
    Kattan, M. W.
    VALUE IN HEALTH, 2009, 12 (07) : A271 - A271
  • [48] Cost-effectiveness of eletriptan versus sumatriptan: Results from a randomized, controlled trial
    Weis, K
    Perfetto, E
    Mullins, CD
    Healey, P
    Subedi, P
    Meng, F
    VALUE IN HEALTH, 2006, 9 (03) : A83 - A83
  • [49] Cost-effectiveness of on-pump and off-pump coronary artery bypass grafting for patients with coronary artery disease: Results from the MASS III trial
    Scudeler, Thiago Luis
    Hueb, Whady A.
    Farkouh, Michael E.
    Maron, David J.
    de Soarez, Patricia Coelho
    Campolina, Alessandro Goncalves
    Takiuti, Myrthes Emy
    Rezende, Paulo Cury
    Godoy, Lucas Colombo
    Hueb, Alexandre Ciapinina
    Lima, Eduardo Gomes
    Garzillo, Cibele Larroza
    Franchini Ramires, Jose Antonio
    Kalil Filho, Roberto
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 273 : 63 - 68
  • [50] Cost and cost-effectiveness analysis of a digital diabetes prevention program: results from the PREDICTS trial
    Michaud, Tzeyu L.
    Wilson, Kathryn E.
    Katula, Jeffrey A.
    You, Wen
    Estabrooks, Paul A.
    TRANSLATIONAL BEHAVIORAL MEDICINE, 2023, 13 (07) : 501 - 510
12345